What to Expect from Treatment Most patients use Sermorelin/Ipamorelin consistently over a period of weeks to months, because benefits related to sleep, recovery, and body composition are typically gradual rather than immediate
Tirzepatide, a dual GIP/GLP-1 agonist, showed up to 20.9% average weight loss in SURMOUNT-1 at 72 weeks
GLP-1 receptor agonists (GLP-1 RAs) are mainly prescribed for people with type 2 diabetes and are not commonly used as a standard treatment for type 1 diabetes, since people with type 1 diabetes do not produce insulin and rely on insulin therapy as their primary treatment
Jang Won Son 1 , Soo Lim 2 Endocrinology and Metabolism 2024;39(2):206-221
No employer can override them for you
For a closer look at how B12 fits into semaglutide formulations, see Semaglutide With B12: What It Is and Whether It Helps